Literature DB >> 9169653

Reversible brain MRI changes in acyclovir neurotoxicity.

M E Blohm1, W Nürnberger, A Aulich, V Engelbrecht, S Burdach.   

Abstract

This case report shows reversible brain MRI changes probably associated with acyclovir toxicity. So far, neuroimaging in acyclovir toxicity had been negative or uninformative. A 12-year-old girl developed focal secondary generalizing epileptic fits following 4 weeks of prophylactic administration of acyclovir (3 x 10 mg/kg body weight/day i.v.) on day +22 after allogeneic peripheral blood stem cell transplantation for CML. Infective causes were excluded. Brain MRI demonstrated multiple gadolinium-enhancing areas with impairment of the blood-brain barrier in cortical and subcortical regions. Clinical symptoms and neuroimaging pathology resolved completely within 9 days of acyclovir withdrawal.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169653     DOI: 10.1038/sj.bmt.1700790

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

Review 1.  Resolution of acyclovir-associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature.

Authors:  W A Watson; N J Rhodes; I A Echenique; M P Angarone; M H Scheetz
Journal:  J Clin Pharm Ther       Date:  2017-03-29       Impact factor: 2.512

2.  Acute confusion in a 55-year-old man with end-stage renal disease.

Authors:  Sheliza Halani; Nisha Andany; Aaron Izenberg; Bourne Auguste
Journal:  CMAJ       Date:  2022-03-21       Impact factor: 16.859

Review 3.  Acute kidney injury and acyclovir-associated encephalopathy after administration of valacyclovir in an elderly person with normal renal function: A case report and literature review.

Authors:  Tsuneaki Kenzaka; Kazuma Sugimoto; Ken Goda; Hozuka Akita
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

4. 

Authors:  Sheliza Halani; Nisha Andany; Aaron Izenberg; Bourne Auguste
Journal:  CMAJ       Date:  2022-08-02       Impact factor: 16.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.